Literature DB >> 16379544

Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital.

Robin Lee1, Mary Beattie, Beth Crawford, Julie Mak, Nicola Stewart, Miriam Komaromy, Laura Esserman, Lucille Shaw, Jane McLennan, Lori Strachowski, Judy Luce, John Ziegler.   

Abstract

Genetic counseling and testing for heritable susceptibility to breast cancer caused by mutations in BRCA genes are largely unavailable to underserved women in the United States. Starting in 2002 the UCSF Cancer Risk Program offered this service free of charge to poor and medically indigent women at San Francisco General Hospital (SFGH). One recruitment strategy was a single-page questionnaire in four languages administered to women waiting for mammograms at SFGH. This report analyzes our first 3 years of experience with the recruitment questionnaire and compares the patient demographics and BRCA test results at SFGH with a more typical population undergoing genetic counseling and testing at UCSF's Mt. Zion Hospital (MZH). To our knowledge this is the first comprehensive clinical service for hereditary breast cancer in a U.S. public hospital. The ethnic mix of all 350 patients counseled was Caucasian 49% (approximately 20% of Caucasians reported Ashkenazi Jewish ancestry), Latina, 26%; African American, 13%; and Asian/other, 12%. Compared to the MZH population, SFGH patients were more ethnically diverse, less educated and more likely to be unemployed. Of 72 patients tested for BRCA mutations, 51 (71%) were negative, 5 were BRCA1 positive, and 12 were BRCA2 positive. Four (1 Caucasian, 1 Latina, 2 African American) had a total of 13 BRCA variants of unknown significance (VUS). The ratio of BRCA1/BRCA2 positive SFGH patients (5/12) was reversed compared to MZH (119/91). We evaluated 4573 recruitment questionnaires and 280 (6%) were judged to represent a high risk of heritable cancer. After additional screening and referral negotiation, 74 were scheduled for counseling. We judged the recruitment questionnaire to be a feasible, efficient, and reasonably cost-effective way to identify women at high risk of hereditary cancer in a traditionally underserved population. Underserved populations present special challenges for genetic counselors because of large, geographically dispersed families, cultural taboos about cancer diagnoses, and social marginalization. Despite these complexities, the clinical service at SFGH has been well accepted by patients and staff. Our successful venture can serve as a model for other public hospitals contemplating this clinical service.

Entities:  

Mesh:

Year:  2005        PMID: 16379544     DOI: 10.1089/gte.2005.9.306

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  18 in total

1.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Authors:  Mary S Beattie; Beth Crawford; Feng Lin; Eric Vittinghoff; John Ziegler
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

2.  To worry or not to worry: breast cancer genetic counseling communication with low-income Latina immigrants.

Authors:  Galen Joseph; Claudia Guerra
Journal:  J Community Genet       Date:  2014-08-23

3.  Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.

Authors:  Teresa K L Boitano; David A Barrington; Sadhvi Batra; Gerald McGwin; Taylor B Turner; Meagan B Farmer; Aimee M Brown; Michael J Straughn; Charles A Leath
Journal:  Gynecol Oncol       Date:  2019-06-10       Impact factor: 5.482

4.  Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.

Authors:  Rena J Pasick; Galen Joseph; Susan Stewart; Celia Kaplan; Robin Lee; Judith Luce; Sharon Davis; Titas Marquez; Tung Nguyen; Claudia Guerra
Journal:  Am J Public Health       Date:  2016-08-23       Impact factor: 9.308

5.  Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.

Authors:  Darren Mays; McKane E Sharff; Tiffani A DeMarco; Bernice Williams; Beth Beck; Vanessa B Sheppard; Beth N Peshkin; Jennifer Eng-Wong; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

6.  Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

Authors:  Daniel H Kim; Beth Crawford; John Ziegler; Mary S Beattie
Journal:  Fam Cancer       Date:  2008-10-15       Impact factor: 2.375

7.  Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.

Authors:  Gabriel N Mannis; Julia E Fehniger; Jennifer S Creasman; Vanessa L Jacoby; Mary S Beattie
Journal:  JAMA Intern Med       Date:  2013-01-28       Impact factor: 21.873

8.  A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings.

Authors:  Huma Q Rana; Sarah R Cochrane; Elaine Hiller; Ruth N Akindele; Callie M Nibecker; Ludmila A Svoboda; Angel M Cronin; Judy E Garber; Christopher S Lathan
Journal:  J Community Genet       Date:  2017-11-18

9.  Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.

Authors:  David A Barrington; Macie L Champion; Teresa K L Boitano; Christen L Walters-Haygood; Meagan B Farmer; Ronald D Alvarez; Jacob M Estes; Charles A Leath
Journal:  Gynecol Oncol       Date:  2018-03-02       Impact factor: 5.482

10.  Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.

Authors:  Julia Fehniger; Feng Lin; Mary S Beattie; Galen Joseph; Celia Kaplan
Journal:  J Genet Couns       Date:  2013-05-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.